PZ Cormay S.A. Logo

PZ Cormay S.A.

Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.

CRM | WAR

Overview

Corporate Details

ISIN(s):
PLCMRAY00029
LEI:
2594006HZJ8OSNK56U87
Country:
Poland
Address:
Warszawa Puławska 303, 02-785 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PZ Cormay S.A. is a manufacturer and distributor of comprehensive solutions for the in-vitro diagnostics (IVD) market. With nearly 40 years of experience, the company specializes in producing high-quality diagnostic reagents and distributing advanced laboratory analyzers. Its product portfolio covers key areas of laboratory medicine, including clinical chemistry, hematology, immunology, and coagulology. The group integrates its reagent manufacturing expertise with the advanced hematology technology of its Swiss subsidiary, Orphee. Cormay provides reliable, high-performance, and cost-effective diagnostic systems to a global network of distributors, clinics, and laboratories for both human and veterinary medicine, committed to delivering trusted test results to aid in accurate medical diagnoses.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-01 09:25
Pre-Annual General Meeting Information
zal01_Ogloszenie_projekty_uchwal_NWZ_PZ_CORMAY_S.A._27.10.2025.pdf
Polish 310.6 KB
2025-10-01 09:25
Report Publication Announcement
Ogłoszenie o zwołaniu NWZ PZ CORMAY S.A. na dzień 27.10.2025 r. (wraz z projekt…
Polish 152 bytes
2025-09-26 07:51
Audit Report / Information
zal02_4._Raport_z_przegladu_PZ_CORMAY_S.A._I_polrocze_2025.pdf
Polish 383.3 KB
2025-09-26 07:51
Audit Report / Information
zal03_3._Raport_z_przegladu_GK_CORMAY_I_polrocze_2025.pdf
Polish 364.5 KB
2025-09-26 07:51
Management Discussion and Analysis
zal04_2._Sprawozdanie_Zarzadu_GK_CORMAY_I_polrocze_2025.pdf
Polish 739.1 KB
2025-09-26 07:51
Interim Report
zal01_1._Sprawozdania_finansowe_GK_CORMAY_PZ_CORMAY_S.A_I_polrocze_2025.pdf
Polish 1.8 MB
2025-09-24 15:26
Related Party Transaction
Zgoda Rady Nadzorczej PZ CORMAY S.A. na zawarcie oraz zawarcie aneksów do umów …
Polish 2.0 KB
2025-05-22 12:27
Post-Annual General Meeting Information
Powołanie osób zarządzających PZ CORMAY S.A. - Content (PL)
Polish 2.9 KB
2025-05-22 12:27
Post-Annual General Meeting Information
Powołanie osób nadzorujących PZ CORMAY S.A. - Content (PL)
Polish 7.4 KB
2025-05-22 12:26
Declaration of Voting Results & Voting Rights Announcements
zal01_RB_5_2025.pdf
Polish 122.4 KB
2025-05-22 12:26
Report Publication Announcement
Lista akcjonariuszy posiadających co najmniej 5% liczby głosów na ZWZ PZ CORMAY…
Polish 152 bytes
2025-05-22 12:25
Post-Annual General Meeting Information
zal01_RB_4_2025.pdf
Polish 357.2 KB
2025-05-22 12:25
Report Publication Announcement
Treść uchwał ZWZ PZ CORMAY S.A., które odbyło się w dniu 22.05.2025 r. - Conten…
Polish 152 bytes
2025-05-16 07:36
Quarterly Report
zal01_Raport_I_kwartal_2025_GK_CORMAY_PZ_CORMAY_S.A..pdf
Polish 1.7 MB
2025-04-25 11:03
Remuneration Information
zal03_Ocena_br_sprawozdanie_o_wynagrodzeniach_2024.pdf
Polish 396.7 KB

Automate Your Workflow. Get a real-time feed of all PZ Cormay S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PZ Cormay S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy FF
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan 4554
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan 4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea 220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea 341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea 456160
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.